MENU
PHVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pharvaris (PHVS) Ownership - Who owns Pharvaris?
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more
Profile
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
810.78M
P/E Ratio
N/A
Total Cash
305.19M
Projected Growth
N/A
Total Debt
116.94K
Revenue
N/A
Risk (Beta)
-3.34
Dividend Yield
N/A
Total Cash/Share
5.63
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PHVS
Capitalization
811M
P/E Ratio
N/A
Risk (Beta)
-3.34
Dividend Yield
N/A
Total Cash
305M
Total Cash/Share
5.63
Total Debt
117K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
297M
P/B Ratio
2.53
Cash Flow
N/A
Earnings
-2.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.51M
Current Ratio
19.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-127.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.80
Shares Held By Institutions
103M
Shares Outstanding - Current
54.2M
Total Liabilities
16.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-22.014
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com